3
2
1

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

2026/07/22

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

2026/04/24

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

2026/03/04

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

2026/02/02

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

2025-09-26

New Research Solves the Problem of Red Blood Cell Cryopreservation, Providing Key Technical Support for Building a Long - Term Blood Bank

This research provides an efficient and safe solution for red blood cell cryopreservation. It also offers important references for the development of preservation technologies for other types of cells such as stem cells and immune cells. It is expected to promote the upgrading of the global blood resource reserve system and provide key technical support for responding to public health emergencies and clinical emergency blood use needs.

2025-09-26

Patient Survives 8 Months after Gene - Edited Pig Kidney Transplant: A Milestone in Xenotransplantation

Recently, Nature News reported a bombshell in the global medical community. Tim Andrews, a 67 - year - old American, has survived eight months after a gene - edited pig kidney transplant. This is not only the longest - lasting case of a pig organ in a living human but also a milestone in xenotransplantation, offering new hope for the global organ shortage.

2025-09-19

Zhejiang University's Run Run Shaw Hospital Develops "Bone Glue", Revolutionizing Orthopedic Treatment

This innovation represents a major breakthrough in China's minimally invasive fracture treatment and brings new hope to global orthopedics.

2025-09-19

"The 'Nobel Prize Indicator': The Lasker Awards Announced - Basic Medicine, Clinical, and Special Achievement Awards Go to Different Recipients

From decoding the cell's "transport code" to developing therapies for genetic diseases, from basic breakthroughs to laying the foundation for disciplines, the 2025 Lasker Award recipients are lighting up the future of medicine with their innovations. As the jury said, "Their work is not only a victory for science but also a milestone in humanity's fight against diseases and exploration of the essence of life."

2025-09-12

New Soft Robots Can Independently Inspect and Melt Ice at Minus 50 Degrees Celsius

Zhang Junshi stated that this research offers new ideas for the development of small intelligent robot systems in extreme environments and broadens the application prospects of new materials in fields such as electronic devices and bionic systems.

2025-09-12

Breaking the Bottleneck! Tsinghua Team's New Technology Enables "Non - Destructive Perspective" of Tissues and Organs

In the future, the team will continue to optimize the universality of the technology, expand its application in plant tissues and clinical pathological samples, and promote its integration with cryo - electron microscopy and super - resolution microscopy, providing key support for precision medicine and intelligent diagnosis. This original achievement is injecting new impetus into global life science research.

< 1...91011...28 >